A
Anthony J. McGoron
Researcher at Florida International University
Publications - 120
Citations - 2250
Anthony J. McGoron is an academic researcher from Florida International University. The author has contributed to research in topics: Imaging phantom & Perfusion. The author has an hindex of 23, co-authored 117 publications receiving 1942 citations. Previous affiliations of Anthony J. McGoron include University of Cincinnati & Louisiana Tech University.
Papers
More filters
Journal ArticleDOI
Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
TL;DR: Nanomedicine approaches in cancer have great potential for clinically translatable advances that can positively impact the overall diagnostic and therapeutic process and result in enhanced quality of life for cancer patients.
Journal ArticleDOI
Biodegradable Magnesium Alloys: A Review of Material Development and Applications
TL;DR: In this Review, a Summary Is Presented for Magnesium Material Development, Biocorrosion Characteristics, as well as a Biological Translation for these Results.
Journal ArticleDOI
Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
TL;DR: Biodegradable poly(DL-lactide-co-glycolic acid) (PLGA) nanoparticles simultaneously loaded with indocyanine green (ICG) and doxorubicin (DOX) were developed using the modified oil in water single emulsion solvent evaporation method.
Journal ArticleDOI
Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells.
Yuan Tang,Anthony J. McGoron +1 more
TL;DR: The combination of photothermal therapy and chemotherapy may provide a valuable tool for cancer treatment with minimized side effect and, though not statistically significant, a synergistic effect may exist between DOX and laser-ICG photothermotherapy.
Journal ArticleDOI
Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms.
Tingjun Lei,Supriya Srinivasan,Yuan Tang,Romila Manchanda,Abhignyan Nagesetti,Alicia Fernandez-Fernandez,Anthony J. McGoron +6 more
TL;DR: It is concluded that cellular uptake and cytotoxicity of doxorubicin can be improved in MES-SA/Dx5 cells by loading DOX into PLGA NPs.